So this did — and made honesty the feature. Real openFDA records, real quotes, real Polymarket contracts, with the source printed on the panel.
Identical edit, audio and timing. Use 4:5 for LinkedIn's mobile feed — it occupies more vertical space, so it holds attention longer — and 16:9 for a desktop feed or YouTube. The 4:5 is the 16:9 framed in the terminal's own chrome, not a crop of it: nothing on screen is cut off.
Bloomberg built a terminal for finance. So we built one for pharma — live FDA authorisations, trial data and biotech quotes, with every figure traceable to its source.
pharmaterminal.aeah.ai
| Symbol | Price | Change | Volume |
|---|---|---|---|
| JNJ | $271.22 | ▲ 0.20% | 4.06M |
| LLY | $1183.46 | ▲ 0.13% | 1.91M |
| MRK | $148.78 | ▲ 0.54% | 8.26M |
| NVS | $145.46 | ▲ 1.32% | 1.17M |
| PFE | $28.67 | ▲ 0.92% | 27.18M |
| BMY | $62.86 | ▲ 2.21% | 10.03M |
| GSK | $49.24 | ▼ 0.83% | 3.29M |
| AZN | $166.58 | ▲ 1.23% | 1.92M |
These are the values read off the running terminal at 2026-09-27 23:29 ET — a frozen snapshot captured for this video, not live prices. The live terminal at pharmaterminal.aeah.ai shows current ones.
Source: openFDA Drugs@FDA submission status dates.
Every number above was read from the live terminal at
pharmaterminal.aeah.ai on 2026-09-27 23:29 ET via the rendered DOM — quotes
with their direction arrows and colours, and approval rows with their drug names,
application types, dates and routes. Nothing is estimated, rounded for effect, or invented.
If a figure could not be read it was left out rather than filled in.
The R&D prediction-markets panel is shown in its empty state on purpose: no pharma-related markets were open on Polymarket at capture time, and unrelated markets are not substituted in.
